Methotrexate

ATP binding cassette subfamily B member 1 ; Homo sapiens







75 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35043269 Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study. 2022 Feb 3
2 35586477 Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report. 2022 2
3 33565324 ABCB1 and SLCO1B1 gene polymorphisms predict methotrexate-resistant for low-risk gestational trophoblastic neoplasia. 2021 Mar 1
4 34744734 The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis. 2021 1
5 32053102 Genetic polymorphism in MDR1 C3435T is a determinant of methotrexate cerebrospinal fluid concentrations in Chinese children with acute lymphoblastic leukemia
. 2020 May 8
6 32271961 The impacts of gene polymorphisms on methotrexate in Chinese psoriatic patients. 2020 Sep 2
7 32926395 Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio. 2020 Dec 1
8 30849662 Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation. 2019 Apr 2
9 30931851 Methotrexate Disposition in Pediatric Patients with Acute Lymphoblastic Leukemia: What Have We Learnt From the Genetic Variants of Drug Transporters. 2019 1
10 30977678 ABCB1 (C1236T) Polymorphism Affects P-Glycoprotein-Mediated Transport of Methotrexate, Doxorubicin, Actinomycin D, and Etoposide. 2019 May 8
11 30983549 Association between ABCB1 C3435T polymorphism and methotrexate treatment outcomes in rheumatoid arthritis patients: a meta-analysis. 2019 Apr 3
12 31311995 A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma. 2019 Jul 16 1
13 31521892 Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis. 2019 Nov 5
14 31685786 Treatment with Methotrexate and Intravenous Cyclophosphamide Pulse Therapy Regulates the P-gp+CD4+ Cell-related Pathogenesis in a Representative Patient with Refractory Proliferative Lupus Nephritis. 2019 4
15 31699188 [High Expression of Multidrug Resistance Gene-1 Can Aggravate Resistance to Methotrexate in Rheumatoid Arthritis Patients]. 2019 Oct 30 1
16 29170124 Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis. 2018 Jan 1 2
17 29252093 Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study. 2018 Jul 1
18 29670920 Methotrexate Combined with 4-Hydroperoxycyclophosphamide Downregulates Multidrug-Resistance P-Glycoprotein Expression Induced by Methotrexate in Rheumatoid Arthritis Fibroblast-Like Synoviocytes via the JAK2/STAT3 Pathway. 2018 11
19 27751863 Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity. 2017 Nov - Dec 2
20 28598776 Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules. 2017 Nov-Dec 1
21 28615105 [Over-expression of mdr1/P-gp is associated with methotrexate resistance in patients with rheumatoid arthritis]. 2017 Jun 6
22 28616661 Clinical relevance of P-glycoprotein activity on peripheral blood mononuclear cells and polymorphonuclear neutrophils to methotrexate in systemic lupus erythematosus patients. 2017 Oct 6
23 28693150 DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells. 2017 Jul 1
24 28710036 Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia. 2017 Sep 10 1
25 26184955 Association of the ABCB1 C3435T polymorphism with responsiveness to and toxicity of DMARDs in rheumatoid arthritis : A meta-analysis. 2016 Sep 3
26 26652611 Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients. 2016 1
27 27322261 TSPO Ligand-Methotrexate Prodrug Conjugates: Design, Synthesis, and Biological Evaluation. 2016 Jun 18 2
28 27323187 Overexpression of P-glycoprotein on fibroblast-like synoviocytes in refractory rheumatoid arthritis patients: a potential mechanism for multidrug resistance in rheumatoid arthritis treatment. 2016 Jun 17 2
29 27533339 Mexican Childhood Acute Lymphoblastic Leukemia: A Pilot Study of the MDR1 and MTHFR Gene Polymorphisms and Their Associations with Clinical Outcomes. 2016 Oct 1
30 27980801 Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population. 2016 1
31 25921280 ABCB1 polymorphisms correlate with susceptibility to adult acute leukemia and response to high-dose methotrexate. 2015 Sep 2
32 26071279 Multidrug resistance 1 (MDR1) 3435C>T gene polymorphism influences the clinical phenotype and methotrexate-induced adverse events in South Indian Tamil rheumatoid arthritis. 2015 Aug 4
33 26353179 Association of ABCB1, ABCC5 and xanthine oxidase genetic polymorphisms with methotrexate adverse reactions in Mexican pediatric patients with ALL. 2015 Sep 2
34 26715450 MDR-1 and MRP-1 activity in peripheral blood leukocytes of rheumatoid arthritis patients. 2015 Dec 30 4
35 24595806 Folates provoke cellular efflux and drug resistance of substrates of the multidrug resistance protein 1 (MRP1). 2014 May 2
36 24680847 Dioscin enhances methotrexate absorption by down-regulating MDR1 in vitro and in vivo. 2014 Jun 1 1
37 25007187 Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. 2014 Aug 6
38 25074866 Association of MDR1 C3435T and RFC1 G80A polymorphisms with methotrexate toxicity and response in Jordanian rheumatoid arthritis patients. 2014 Sep 5
39 25303299 Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. 2014 Aug 1
40 24229684 Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein. 2013 Nov 1
41 21887680 Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study. 2012 Apr 1 1
42 22104130 Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis. 2012 2
43 22796246 ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis. 2012 Aug 1
44 22859359 ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis. 2012 Oct 3
45 23095111 Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis. 2012 Nov 2
46 21062675 Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A: modulation of P-glycoprotein function. 2011 Jan 2
47 21387541 Polymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemia. 2011 Oct 1
48 21509569 Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma. 2011 Oct 1
49 21868524 Anti-MDR1 siRNA restores chemosensitivity in chemoresistant breast carcinoma and osteosarcoma cell lines. 2011 Sep 1
50 21948322 Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors. 2011 Dec 1